Skip to content
Tenfell
Closed tender
Published 19 Oct 2020

UK Antibodies Supply

Department for Business, Energy & Industrial Strategy · United Kingdom

Key facts

Estimated value
£1
Closing date
23 Dec 2020
Contract starts
31 Mar 2021
Contract ends
30 Jun 2022
Buyer type
Central government

Description

COVID-19 requires over 500,000 'at risk' people in the UK to be protected via antibody prophylaxis as they are unlikely to benefit from a vaccine. Demand for antibody prophylaxis is estimated at up to 1.5million 1g doses of an antibody cocktail (containing two antibodies @0.5g each) per annum. Current UK manufacturing supply chains do not have capacity to produce these levels. To secure this and ensure the UK is best placed to respond to future requirements, by assuring supply chain resilience and access, the Department is seeking to engage the market to explore how UK antibody manufacturing capability can be developed. The target is for capability to reach 1.5m 1g doses of antibody cocktail pa under Good Manufacturing Process by the end of Q2 2022.

Categories (CPV)

Similar open tenders

About Department for Business, Energy & Industrial Strategy

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.